Poišči alternative:
compas can » compass can (Razširi iskanje), compass cat (Razširi iskanje), company can (Razširi iskanje)
compared a » compared _ (Razširi iskanje)
al compas » _ compas (Razširi iskanje), y compas (Razširi iskanje)
camp can » clamp can (Razširi iskanje), camp ca (Razširi iskanje), amp can (Razširi iskanje)
can netw » can new (Razširi iskanje), can net (Razširi iskanje), can newts (Razširi iskanje)
can now » can non (Razširi iskanje), can new (Razširi iskanje), can ngoc (Razširi iskanje)
al camp » al campo (Razširi iskanje), al campa (Razširi iskanje), al campus (Razširi iskanje)
_ cml » _ cmv (Razširi iskanje), _ cmr (Razširi iskanje)
a non » _ non (Razširi iskanje)
j al » j a (Razširi iskanje), j l (Razširi iskanje)
A mostrar 1 - 20 resultados de 331 para a pesquisa '(((( j al compas can now ) OR ( ((_ pml) OR (_ cml)) compared a non ))) OR ( j al camp can netw ))', čas poizvedbe: 0.94seg Refinar resultados
Besifloxacin Ophthalmic Suspension: Emerging Evidence of its Therapeutic Value in Bacterial Conjunctivitis
Survival Patterns in United States (US) Medicare Enrollees with Non-CML Myeloproliferative Neoplasms (MPN)

Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
The human regulatory protein Ki-1/57 is a target of SUMOylation and affects PML nuclear bodies formation

TNF Polymorphism Affects Transplant Outcome in Patients with MDS but not with CML, Independent of the Presence of HLA-DR15
Three cases of non-carryover fingolimod-PML: Is the risk in Japan increased?

Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI
Clinical Study of Advanced Glycation End Products in Egyptian Diabetic Obese and Non-Obese Patients

High Disease-Free Survival with Enhanced Protection Against Relapse After Double-Unit Cord Blood Transplantation when Compared to T-cell Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia
The national incidence of PML in Sweden, 1988–2013

Presence of Simian Virus 40 DNA Sequences in Egyptian Patients with Lymphoproliferative Disorders
TET2 Single Nucleotide Polymorphism in Myeloid Neoplasms Among Egyptian Patients

The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells
MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients

Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
COVID-19-Induced Pancytopenia in a Major Molecular Response CML Patient on Dasatinib: A Case Report and Review of the Literature

Iskalna orodja: RSS — Pošljite iskanje po emailu — Shrani iskanje